^○Yoshihiro NABESHIMA¹, Kazuya ISODA¹, Junichi GOTO², Maiko IKEDA¹, Sakura SATO¹, masakazu ICHIHASHI¹, sachi YAMASHIRO¹ (1. Yuge Hospiltal, Kumamoto, Japan, 2. Kumamoto prefectual mental care center, Kumamoto, Japan)

^○Tamaki OWADA¹, Masataka SHINOZAKI¹, Narihiro NOZAWA², Tsunetoshi MORI³, Harunobu MORI³, Koichi HIRATA², Kazutaka SHIMODA¹ (1. Department of Psychiatry Dokkyo Medical University , 2. Department of Neurology Dokkyo Medical University, 3. Mori Hospital)

^○Kazuya MORITA¹, Tetsu TOMITA², Junji SARUWATARI¹, Mikito UEDA³, Akiko AOKI³, Shoko TSUCHIMINE², Kazuma IWASHITA¹, Miki NISHIMURA¹, Kentaro ONIKI¹, kazutaka SHIMODA³, Norio FURUKORI³ (1. Department of Pharmacology and Therapeutics, Kumamoto University, Kumamoto, Japan, 2. Department of Neuropsychiatry, Hirosaki University, 3. Department of Psychiatry, Dokkyo Medical University)

^○Takeo SAIO^{1, 2} (1. Department of Psychiatry, Fuji Toranomon Orthopedic Hospital, 2. Health Management Office, SMBC Nikko Securities)